Middle East and Africa Mobile ECG Devices Market is expected to reach US$ 93.27 Million by 2028

PRESS RELEASE BY The Insight Partners 10 Feb 2022

Share this press on

The personal users segment by end user is estimated to lead the market growth during the forecast period.

According to The Insight Partners market research study of “Middle East and Africa Mobile ECG Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type, Modality, End User and Country.” The Middle East and Africa mobile ECG devices market is expected to reach US$ 93.27 million by 2028 from US$ 74.25 million in 2021; it is estimated to grow at a CAGR of 3.6% from 2021 to 2028. The report highlights trends prevailing in the Middle East and Africa mobile ECG devices market and the factors driving market along with those that act as hindrances.

The mobile ECG devices market players are focusing their R&D capabilities for developing technologically advanced products. The traditional counterparts of these devices are uncomfortable to use and can be worn for a limited periods. Thus, the current and ongoing development associated with the mobile devices helped the players to enter the consumer market at a significant rate. The adoption for mobile ECG devices is increasing with growing investments in healthcare infrastructure and rise in acceptance for modern technologies. The notable benefits of these devices include convenience, ease of use, and continuous monitoring, which ensure accuracy in results and improved treatment effectiveness. The increasing awareness regarding the need of the early detection and management of CVDs and other heart problems propels the demand for mobile ECG devices. Additionally, with the technological advancements, mobile systems have emerged as a cost-effective strategy for consumer care. The commercially advanced devices enabled with the Bluetooth sensor technology and equipped with mobile apps drive the popularity of mobile ECG devices, which are worn continuously by patients. Such devices send ECG readings to users’ smartphones that are connected to the devices via Bluetooth. In the last 5 years, there has been an enormous surge in the adoption of wearable and handheld ECG devices, and the associated smartphone apps that allow consumers to record 1–6-lead ECG. Clinical studies also highlight the high sensitivity of wireless mobile ECG devices, which helps detect atrial fibrillation and other cardiac abnormalities at any time, through interactions between the device and user, mediated by smartphones that help overcome constraints of place and time. As a result, the healthcare professionals can receive automated updates, which allows them to offer structured CVD management and minimize clinical visits.

The mobile ECG devices market is characterized by the presence of many small and big companies. The market players are adopting strategies such as new product launches and partnerships to increase their market share and gain a competitive edge over other players.  The AliveCor’s Kardia devices allow iPhones and Kardia watch to record an ECG within 30-second, and with the help of AI algorithms, the devices automatically examine the waveforms for various arrhythmias. Medtronic wearable, clinical-grade, stick-on cardiac monitor, offers interfaces with patients' mobile devices to help them mark the heart events and allow data transmission to a clinician's office or automated ECG monitoring system. Thus, advancements in mobile ECG products and other strategies by key market players are leading to significant trends in the mobile ECG devices market.

The COVID-19 pandemic has become the most significant challenge in the Middle East and Africa. Many countries in the region have underdeveloped and underfunded healthcare systems. The sudden emergence of SARS-CoV-2 exerted severe pressure on healthcare facilities in the region. Furthermore, the shortage of hospital supplies is accelerating the criticality of the condition. The shift in focus of healthcare professionals during the early stages of the pandemic on the management of COVID-19 case, substantially hampered the number of other diagnostic procedures and elective surgeries in the region. The spread of SARS-CoV-2 caused heavy burdens on healthcare professionals. Cardiac surgeons were overloaded with emergency cardiac surgeries, COVID patient management, and safety guidelines implementation to prevent the spread of the virus. Therefore, empowering family physicians and their patients with accurate and portable home diagnostic devices, including electrocardiogram (ECG) devices and oximeters became a priority in Asia-Pacific countries. Moreover, the implementation of social distancing policies resulted into limited patients visits to cardiac centers, which drastically lowered the demand and adoption of mobile ECG devices in Middle East and Africa. Apart from this, a huge population already faces a large burden of noncommunicable diseases, making them more vulnerable to the novel coronavirus. However, the launch of COVID-19 vaccination programs in several countries would ultimately improve the situation in the coming years.

The Middle East and Africa mobile ECG devices market, based on type, has been segmented into monitoring ECG systems and diagnostic ECG systems. The Middle East and Africa mobile ECG devices market, based on application, is segmented into handheld, band, pen, and others. The Middle East and Africa mobile ECG devices market, based on end user, is segmented into personal users, hospitals and clinics, and ambulatory services. Geographically, the Middle East and Africa mobile ECG devices market is sub-segmented into UAE, South Africa, Saudi Arabia and Rest of Middle East and Africa.

Koninklijke Philips N.V., Medtronic, AliveCor, Inc, and Nihon Kohden Corporation are among the leading companies operating in the Middle East and Africa mobile ECG devices market.

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com


Download Free PDF Brochure